We’re excited to share fantastic funding news! Cancer Foundation Finland has awarded grants to several research groups at Turku Bioscience. In 2024, the foundation allocated a record-breaking total of over 7.7 million euros to support Read more
We’re excited to share fantastic funding news! Cancer Foundation Finland has awarded grants to several research groups at Turku Bioscience. In 2024, the foundation allocated Read more
A new method for producing blood stem cells may in the future replace voluntary bone marrow donors as a source of stem cell transplants. Four Read more
The Novo Nordisk Foundation awarded 2024 grants to five researchers from the University of Turku, totaling approximately €2,204,294. Among the grant recipients were: Docent, InFLAMES Read more
We are happy to announce that a new research group is starting at Turku Bioscience. Led by Jonna Alanko, the group currently consists of three Read more
InFLAMES group leader, Docent Carlos Rogerio Figueiredo, has received the Young Investigator Award from the Scandinavian Society for Immunology. The award was announced at the Read more
Frontiers of Science seminar program is ready for autumn 2024. All seminars are on-site only at 12:00. Coffee and sandwich are served before each seminar. Read more
The NAP4DIVE project of TBC group leaders Cecilia Sahlgren and Hongbo Zhang were awarded 7.8 MEUR of Horizon Europe funding (Total 7.8 million euro, ÅAU Read more
Modern cancer treatment aims for the most effective treatment possible, which would cause the patients as few side effects as possible. The individual choice of Read more
The Research Council of Finland /Academy of Finland Scientific Council for Biosciences, Health and the Environment has granted generous funding to two research projects at Read more
Treatment outcomes for breast cancer have become better over the years, but proportion of breast cancers still recur even after long periods without signs of Read more
Last updated on June 25, 2025
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
